The US Federal Trade Commission this week asked both MDS and Danaher for more information concerning the proposed sale of MDS Analytical Technologies to Danaher, pushing back the anticipated closing of deals that would create a new mass spec giant in Danaher to the first quarter of 2010.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.